608 related articles for article (PubMed ID: 30367578)
1. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
Feng H; Li T; Zhang X
BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
[TBL] [Abstract][Full Text] [Related]
2. RNA splicing and splicing regulator changes in prostate cancer pathology.
Munkley J; Livermore K; Rajan P; Elliott DJ
Hum Genet; 2017 Sep; 136(9):1143-1154. PubMed ID: 28382513
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells.
Lindqvist J; Imanishi SY; Torvaldson E; Malinen M; Remes M; Örn F; Palvimo JJ; Eriksson JE
Mol Biol Cell; 2015 Jun; 26(11):1971-84. PubMed ID: 25851605
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
5. Identifying differentially spliced genes from two groups of RNA-seq samples.
Wang W; Qin Z; Feng Z; Wang X; Zhang X
Gene; 2013 Apr; 518(1):164-70. PubMed ID: 23228854
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome.
Rajan P; Dalgliesh C; Carling PJ; Buist T; Zhang C; Grellscheid SN; Armstrong K; Stockley J; Simillion C; Gaughan L; Kalna G; Zhang MQ; Robson CN; Leung HY; Elliott DJ
PLoS One; 2011; 6(12):e29088. PubMed ID: 22194994
[TBL] [Abstract][Full Text] [Related]
7. A benchmarking of workflows for detecting differential splicing and differential expression at isoform level in human RNA-seq studies.
Merino GA; Conesa A; Fernández EA
Brief Bioinform; 2019 Mar; 20(2):471-481. PubMed ID: 29040385
[TBL] [Abstract][Full Text] [Related]
8. Studying Isoform-Specific mRNA Recruitment to Polyribosomes with Frac-seq.
Martinez-Nunez RT; Sanford JR
Methods Mol Biol; 2016; 1358():99-108. PubMed ID: 26463379
[TBL] [Abstract][Full Text] [Related]
9. Alternative Splicing Signatures in RNA-seq Data: Percent Spliced in (PSI).
Schafer S; Miao K; Benson CC; Heinig M; Cook SA; Hubner N
Curr Protoc Hum Genet; 2015 Oct; 87():11.16.1-11.16.14. PubMed ID: 26439713
[TBL] [Abstract][Full Text] [Related]
10. Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.
Hu DG; McKinnon RA; Hulin JA; Mackenzie PI; Meech R
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035996
[TBL] [Abstract][Full Text] [Related]
11. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
F1000Res; 2018; 7():1189. PubMed ID: 30271587
[No Abstract] [Full Text] [Related]
12. Differential splicing analysis based on isoforms expression with NBSplice.
Merino GA; Fernández EA
J Biomed Inform; 2020 Mar; 103():103378. PubMed ID: 31972288
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing regulation by the androgen receptor in prostate cancer cells.
Germain L; Lafront C; Beaudette J; Karthik Poluri RT; Weidmann C; Audet-Walsh É
J Steroid Biochem Mol Biol; 2020 Sep; 202():105710. PubMed ID: 32534106
[TBL] [Abstract][Full Text] [Related]
14. Targeting Splicing in Prostate Cancer.
Antonopoulou E; Ladomery M
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29693622
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
16. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.
Ozen M; Ittmann M
Clin Cancer Res; 2005 Jul; 11(13):4701-6. PubMed ID: 16000564
[TBL] [Abstract][Full Text] [Related]
17. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.
Hsu FN; Chen MC; Chiang MC; Lin E; Lee YT; Huang PH; Lee GS; Lin H
J Biol Chem; 2011 Sep; 286(38):33141-9. PubMed ID: 21799006
[TBL] [Abstract][Full Text] [Related]
18. A novel model used to detect differential splice junctions as biomarkers in prostate cancer from RNA-Seq data.
Rezaeian I; Tavakoli A; Cavallo-Medved D; Porter LA; Rueda L
J Biomed Inform; 2016 Apr; 60():422-30. PubMed ID: 26992567
[TBL] [Abstract][Full Text] [Related]
19. Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
Wang J; Ye Z; Huang TH; Shi H; Jin VX
Methods Mol Biol; 2017; 1513():163-170. PubMed ID: 27807836
[TBL] [Abstract][Full Text] [Related]
20. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
